ZYNOFARMA
Active Risk: not assessedSummary
ZYNOFARMA is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
History
Acts, filings and financial milestones
2025
03-11
Gazette deed
IncorporationAppointment: ESQUENET Christophe (director) · Founder · Founding capital10 facts ▸
Gazette deed
Incorporation
Appointment: ESQUENET Christophe (director) · Founder · Founding capital10 facts ▸
- Incorporation, 28-10-2025
- Founder, MEHTA Meghal Narendrakumar
- Founder, ESQUENET Christophe
- Founding capital, €25,000
- Bank account, “bijzondere rekening” (deed in Dutch)
- Registered office clause, “3800 Sint-Truiden, Minderbroedersstraat 6” (deed in Dutch)
- Board rule, 1
- Director appointment, ESQUENET Christophe (director (not named in the articles))
- Pre-incorporation commitments, “takeover, alle verbintenissen en alle verplichtingen die eruit voortvloeien, en alle activiteiten” (deed in Dutch)
- Power of attorney, D&D Consulting
Gazette deed
1 of 1 deed read